C M Apovian1, M R Singer, W W Campbell, S Bhasin, A C McCarthy, M Shah, S Basaria, L L Moore. 1. Caroline M. Apovian, MD, Section of Endocrinology, Diabetes, Nutrition and Weight Management, Boston Medical Center, Boston University School of Medicine, 88 East Newton Street, Robinson 4400, Boston, MA 02118, 617-638-8556 (Phone), 617-638-8599 (Fax), (caroline.apovian@bmc.org).
Abstract
OBJECTIVES: Nutrition impacts the development of sarcopenia and protein intake is an important modulator of skeletal muscle mass loss in older people. The Optimizing Protein Intake in Older Men with Mobility Limitation (OPTIMEN) Trial was designed to assess the independent and combined effects of higher protein intake and a promyogenic agent, testosterone, on lean body mass, muscle strength and physical function in older men with mobility disability. The purpose of this paper is to describe the experimental design and nutrition intervention, including techniques used by research dietitians to develop and deliver energy and protein-specific meals to the homes of community-dwelling participants. Strategies to enhance long-term dietary compliance are detailed. DESIGN: Randomized, double-blind, placebo-controlled six-month intervention trial. SETTING:Participants were recruited from Boston MA USA and surrounding communities. PARTICIPANTS: Older men who were mobility-limited (Short Physical Performance Battery (SPPB) 3-10) and consuming less protein (<0.83 g/kg/day) were recruited for this study. INTERVENTION: Here we report the successful implementation of a double-blind, placebo-controlled, parallel group, randomized controlled trial with a 6-month intervention period among community-living men, age 65 years and older with a mobility limitation. A controlled feeding plan was used to deliver required energy intakes and prescribed protein quantities of 0.8 or 1.3 grams/kilogram/day (g/kg/d) in three meals plus snacks and supplements. A 2x2 factorial design was used to assess the effects of protein level alone and in combination with testosterone (vs. placebo) on changes in lean body mass (primary outcome), muscle strength, and physical function. RESULTS: A total of 154 men met the eligibility criteria; 112 completed a 2-week run-in period designed to evaluate compliance with the nutrition intervention. Of these, 92 subjects met compliance eligibility criteria and agreed to be randomized; 85% completed the full trial. The study successfully delivered three meals per day to subjects, with a high degree of compliance and subject satisfaction. Overall self-reported compliance rates were 80% and 93% for the meals and supplements, respectively. Details of compliance strategies are discussed. CONCLUSION: This community-based study design may serve as a model for longer-term nutritional interventions requiring monitoring of dietary compliance in a home-based feeding and supplementation trial.
RCT Entities:
OBJECTIVES: Nutrition impacts the development of sarcopenia and protein intake is an important modulator of skeletal muscle mass loss in older people. The Optimizing Protein Intake in Older Men with Mobility Limitation (OPTIMEN) Trial was designed to assess the independent and combined effects of higher protein intake and a promyogenic agent, testosterone, on lean body mass, muscle strength and physical function in older men with mobility disability. The purpose of this paper is to describe the experimental design and nutrition intervention, including techniques used by research dietitians to develop and deliver energy and protein-specific meals to the homes of community-dwelling participants. Strategies to enhance long-term dietary compliance are detailed. DESIGN: Randomized, double-blind, placebo-controlled six-month intervention trial. SETTING:Participants were recruited from Boston MA USA and surrounding communities. PARTICIPANTS: Older men who were mobility-limited (Short Physical Performance Battery (SPPB) 3-10) and consuming less protein (<0.83 g/kg/day) were recruited for this study. INTERVENTION: Here we report the successful implementation of a double-blind, placebo-controlled, parallel group, randomized controlled trial with a 6-month intervention period among community-living men, age 65 years and older with a mobility limitation. A controlled feeding plan was used to deliver required energy intakes and prescribed protein quantities of 0.8 or 1.3 grams/kilogram/day (g/kg/d) in three meals plus snacks and supplements. A 2x2 factorial design was used to assess the effects of protein level alone and in combination with testosterone (vs. placebo) on changes in lean body mass (primary outcome), muscle strength, and physical function. RESULTS: A total of 154 men met the eligibility criteria; 112 completed a 2-week run-in period designed to evaluate compliance with the nutrition intervention. Of these, 92 subjects met compliance eligibility criteria and agreed to be randomized; 85% completed the full trial. The study successfully delivered three meals per day to subjects, with a high degree of compliance and subject satisfaction. Overall self-reported compliance rates were 80% and 93% for the meals and supplements, respectively. Details of compliance strategies are discussed. CONCLUSION: This community-based study design may serve as a model for longer-term nutritional interventions requiring monitoring of dietary compliance in a home-based feeding and supplementation trial.
Entities:
Keywords:
Protein intake; elderly; meal provision; nutrition design
Authors: Shalender Bhasin; Caroline M Apovian; Thomas G Travison; Karol Pencina; Grace Huang; Lynn L Moore; Wayne W Campbell; Andrew Howland; Ruo Chen; Martha R Singer; Mitali Shah; Richard Eder; Haley Schram; Richelle Bearup; Yusnie M Beleva; Ashley C McCarthy; Zhouying Li; Erin Woodbury; Jennifer McKinnon; Thomas W Storer; Shehzad Basaria Journal: Contemp Clin Trials Date: 2017-05-05 Impact factor: 2.226
Authors: P A Quatromoni; D L Copenhafer; S Demissie; R B D'Agostino; C E O'Horo; B-H Nam; B E Millen Journal: J Epidemiol Community Health Date: 2002-05 Impact factor: 3.710
Authors: Minghua Tang; George P McCabe; Rajavel Elango; Paul B Pencharz; Ronald O Ball; Wayne W Campbell Journal: Am J Clin Nutr Date: 2014-01-15 Impact factor: 7.045
Authors: Tari D Topolski; James LoGerfo; Donald L Patrick; Barbara Williams; Julie Walwick; Marsha B Patrick Journal: Prev Chronic Dis Date: 2006-09-15 Impact factor: 2.830
Authors: Shalender Bhasin; Caroline M Apovian; Thomas G Travison; Karol Pencina; Lynn L Moore; Grace Huang; Wayne W Campbell; Zhuoying Li; Andrew S Howland; Ruo Chen; Philip E Knapp; Martha R Singer; Mitali Shah; Kristina Secinaro; Richard V Eder; Kathleen Hally; Haley Schram; Richelle Bearup; Yusnie M Beleva; Ashley C McCarthy; Erin Woodbury; Jennifer McKinnon; Geeta Fleck; Thomas W Storer; Shehzad Basaria Journal: JAMA Intern Med Date: 2018-04-01 Impact factor: 21.873
Authors: Christine Baldwin; Marian Ae de van der Schueren; Hinke M Kruizenga; Christine Elizabeth Weekes Journal: Cochrane Database Syst Rev Date: 2021-12-21
Authors: Grace Huang; Karol Pencina; Zhuoying Li; Caroline M Apovian; Thomas G Travison; Thomas W Storer; Thiago Gagliano-Jucá; Shehzad Basaria; Shalender Bhasin Journal: J Gerontol A Biol Sci Med Sci Date: 2021-05-22 Impact factor: 6.053